Detalles de la búsqueda
1.
Neutrophil-to-lymphocyte ratio as a predictor of survival in patients with triple-negative breast cancer.
Breast Cancer Res Treat
; 174(2): 443-452, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30604000
2.
Retrospective Analysis of Treatment Patterns and Effectiveness of Palbociclib and Subsequent Regimens in Metastatic Breast Cancer.
J Natl Compr Canc Netw
; 17(2): 141-147, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30787127
3.
Serum thymidine kinase 1 activity as a pharmacodynamic marker of cyclin-dependent kinase 4/6 inhibition in patients with early-stage breast cancer receiving neoadjuvant palbociclib.
Breast Cancer Res
; 19(1): 123, 2017 Nov 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-29162134
4.
Genomic Complexity Predicts Resistance to Endocrine Therapy and CDK4/6 Inhibition in Hormone Receptor-Positive (HR+)/HER2-Negative Metastatic Breast Cancer.
Clin Cancer Res
; 29(9): 1719-1729, 2023 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36693175
5.
A phase II trial of an alternative schedule of palbociclib and embedded serum TK1 analysis.
NPJ Breast Cancer
; 8(1): 35, 2022 Mar 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-35314693
6.
The Phase II MutHER Study of Neratinib Alone and in Combination with Fulvestrant in HER2-Mutated, Non-amplified Metastatic Breast Cancer.
Clin Cancer Res
; 28(7): 1258-1267, 2022 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35046057
7.
NeoPalAna: Neoadjuvant Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, and Anastrozole for Clinical Stage 2 or 3 Estrogen Receptor-Positive Breast Cancer.
Clin Cancer Res
; 23(15): 4055-4065, 2017 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28270497
8.
Neratinib Efficacy and Circulating Tumor DNA Detection of HER2 Mutations in HER2 Nonamplified Metastatic Breast Cancer.
Clin Cancer Res
; 23(19): 5687-5695, 2017 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28679771
9.
Localization of a mutant p53 response element on the tissue inhibitor of metalloproteinase-3 promoter: mutant p53 activities are distinct from wild-type.
Cancer Lett
; 240(1): 48-59, 2006 Aug 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-16236433
10.
A Phase I Trial of BKM120 (Buparlisib) in Combination with Fulvestrant in Postmenopausal Women with Estrogen Receptor-Positive Metastatic Breast Cancer.
Clin Cancer Res
; 22(7): 1583-91, 2016 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26563128
Resultados
1 -
10
de 10
1
Próxima >
>>